Taiwan · Delayed Price · Currency is TWD Synmosa Biopharma Statistics
Total Valuation
TPEX:4114 has a market cap or net worth of TWD 16.06 billion. The enterprise value is 16.98 billion.
| Market Cap | 16.06B |
| Enterprise Value | 16.98B |
Important Dates
The next estimated earnings date is Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | Jul 11, 2025 |
Share Statistics
TPEX:4114 has 502.77 million shares outstanding. The number of shares has increased by 7.00% in one year.
| Current Share Class | 502.77M |
| Shares Outstanding | 502.77M |
| Shares Change (YoY) | +7.00% |
| Shares Change (QoQ) | -0.56% |
| Owned by Insiders (%) | 9.38% |
| Owned by Institutions (%) | 6.89% |
| Float | 389.48M |
Valuation Ratios
The trailing PE ratio is 19.25.
| PE Ratio | 19.25 |
| Forward PE | n/a |
| PS Ratio | 2.60 |
| PB Ratio | 1.59 |
| P/TBV Ratio | 1.93 |
| P/FCF Ratio | 102.88 |
| P/OCF Ratio | 39.03 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.61, with an EV/FCF ratio of 108.76.
| EV / Earnings | 20.66 |
| EV / Sales | 2.74 |
| EV / EBITDA | 15.61 |
| EV / EBIT | 22.58 |
| EV / FCF | 108.76 |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.25.
| Current Ratio | 2.95 |
| Quick Ratio | 1.93 |
| Debt / Equity | 0.25 |
| Debt / EBITDA | 2.26 |
| Debt / FCF | 16.10 |
| Interest Coverage | 12.55 |
Financial Efficiency
Return on equity (ROE) is 6.69% and return on invested capital (ROIC) is 5.95%.
| Return on Equity (ROE) | 6.69% |
| Return on Assets (ROA) | 3.70% |
| Return on Invested Capital (ROIC) | 5.95% |
| Return on Capital Employed (ROCE) | 6.64% |
| Weighted Average Cost of Capital (WACC) | 4.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.47 |
| Inventory Turnover | 1.74 |
Taxes
In the past 12 months, TPEX:4114 has paid 181.22 million in taxes.
| Income Tax | 181.22M |
| Effective Tax Rate | 22.66% |
Stock Price Statistics
The stock price has increased by +12.63% in the last 52 weeks. The beta is 0.02, so TPEX:4114's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | +12.63% |
| 50-Day Moving Average | 31.68 |
| 200-Day Moving Average | 33.36 |
| Relative Strength Index (RSI) | 59.25 |
| Average Volume (20 Days) | 711,804 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4114 had revenue of TWD 6.19 billion and earned 821.85 million in profits. Earnings per share was 1.66.
| Revenue | 6.19B |
| Gross Profit | 2.68B |
| Operating Income | 778.52M |
| Pretax Income | 799.64M |
| Net Income | 821.85M |
| EBITDA | 1.09B |
| EBIT | 778.52M |
| Earnings Per Share (EPS) | 1.66 |
Balance Sheet
The company has 2.93 billion in cash and 2.51 billion in debt, with a net cash position of 418.19 million or 0.83 per share.
| Cash & Cash Equivalents | 2.93B |
| Total Debt | 2.51B |
| Net Cash | 418.19M |
| Net Cash Per Share | 0.83 |
| Equity (Book Value) | 10.10B |
| Book Value Per Share | 17.43 |
| Working Capital | 4.41B |
Cash Flow
In the last 12 months, operating cash flow was 411.57 million and capital expenditures -255.44 million, giving a free cash flow of 156.14 million.
| Operating Cash Flow | 411.57M |
| Capital Expenditures | -255.44M |
| Depreciation & Amortization | 308.40M |
| Net Borrowing | -46.35M |
| Free Cash Flow | 156.14M |
| FCF Per Share | 0.31 |
Margins
Gross margin is 43.28%, with operating and profit margins of 12.58% and 13.28%.
| Gross Margin | 43.28% |
| Operating Margin | 12.58% |
| Pretax Margin | 12.92% |
| Profit Margin | 13.28% |
| EBITDA Margin | 17.56% |
| EBIT Margin | 12.58% |
| FCF Margin | 2.52% |
Dividends & Yields
This stock pays an annual dividend of 0.55, which amounts to a dividend yield of 1.71%.
| Dividend Per Share | 0.55 |
| Dividend Yield | 1.71% |
| Dividend Growth (YoY) | 9.82% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 33.17% |
| Buyback Yield | -7.00% |
| Shareholder Yield | -5.29% |
| Earnings Yield | 5.12% |
| FCF Yield | 0.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 11, 2025. It was a forward split with a ratio of 1.099848595.
| Last Split Date | Jul 11, 2025 |
| Split Type | Forward |
| Split Ratio | 1.099848595 |
Scores
TPEX:4114 has an Altman Z-Score of 3.6 and a Piotroski F-Score of 7.
| Altman Z-Score | 3.6 |
| Piotroski F-Score | 7 |